إيدوكسابان توسيلات
| Kind | API |
|---|---|
| Class | Anticoagulant — direct oral factor Xa inhibitor (DOAC) |
| Synonyms | DU-176b, edoxaban tosilate monohydrate, Lixiana, Savaysa |
| Common uses / forms | Oral tablets 15 / 30 / 60 mg; stroke prevention in AF, VTE treatment |
| Properties | Tosilate monohydrate salt; pH-dependent solubility (higher in acid); oral bioavailability ~62%; low-dose content uniformity sensitive |
| Sourcing origins | India, China, Japan |
| Dominant inbound route | Hormuz |
| Indicative price band | $$$$ (> $1000 / kg) |
| Indicative lead time | medium (50–80 days) |
| Notes | Newer DOAC — public compendial monograph coverage limited, so qualify against innovator/CEP specs; Daiichi Sankyo originator, still patent-protected in several markets |
Open the interactive Data Bank (363 substances) · the full table · Supply Resilience Studio
Share: LinkedIn · X · WhatsApp · Telegram · Email
Cite as: AUPAM Experts' Office, Edoxaban tosylate — sourcing profile (API) — AUPAM Data Bank, retrieved 2026-08-31, https://aupameo.org/datasets/databank/a-edoxaban-tosylate.html